SETHOTOPE
LOE ApproachingNDAINJECTIONINJECTABLEPriority Review
Approved
May 1973
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 22h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SETHOTOPE is an injectable diagnostic or radiopharmaceutical product approved in 1973 by Bracco, a leading diagnostic imaging company. The specific mechanism of action and therapeutic indications are not publicly detailed in available data, but the injectable formulation suggests use in imaging or diagnostic procedures. This legacy product represents a foundational component of Bracco's portfolio in nuclear medicine or contrast agent space.
LOE Approaching
As a legacy product approaching loss of exclusivity after 50+ years on market, commercial teams are likely in maintenance or transition mode with minimal headcount expansion planned.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SETHOTOPE offers stable, specialist-level career opportunities in a mature diagnostic product requiring operational excellence and regulatory expertise. This is a maintenance product ideal for professionals seeking established processes and predictable workflows rather than innovation-focused careers.
Diagnostic Product SpecialistQuality Assurance Manager
Worked on SETHOTOPE at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.